A Framework for Integrating Telehealth Equitably across the cancer care continuum

Katharine A. Rendle*, Andy S.L. Tan, Bonnie Spring, Erin M. Bange, Allison Lipitz-Snyderman, Michael J. Morris, Danil V. Makarov, Robert Daly, Sofia F. Garcia, Brian Hitsman, Olugbenga Ogedegbe, Siobhan Phillips, Scott E. Sherman, Peter D. Stetson, Anil Vachani, Jocelyn V. Wainwright, Leah L. Zullig, Justin E. Bekelman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

The COVID-19 pandemic placed a spotlight on the potential to dramatically increase the use of telehealth across the cancer care continuum, but whether and how telehealth can be implemented in practice in ways that reduce, rather than exacerbate, inequities are largely unknown. To help fill this critical gap in research and practice, we developed the Framework for Integrating Telehealth Equitably (FITE), a process and evaluation model designed to help guide equitable integration of telehealth into practice. In this manuscript, we present FITE and showcase how investigators across the National Cancer Institute’s Telehealth Research Centers of Excellence are applying the framework in different ways to advance digital and health equity. By highlighting multilevel determinants of digital equity that span further than access alone, FITE highlights the complex and differential ways structural determinants restrict or enable digital equity at the individual and community level. As such, achieving digital equity will require strategies designed to not only support individual behavior but also change the broader context to ensure all patients and communities have the choice, opportunity, and resources to use telehealth across the cancer care continuum.

Original languageEnglish (US)
Pages (from-to)92-99
Number of pages8
JournalJournal of the National Cancer Institute - Monographs
Volume2024
Issue number64
DOIs
StatePublished - Jul 1 2024

Funding

KAR reported receiving grants from Pfizer and AstraZeneca paid to her institution, personal fees from Merck for serving as a scientific consultant, and honoraria and travel paid as invited speaker from MJH Life Sciences outside the submitted work. EMB reported consulting fees from Flatiron Health. MJM reported receiving personal fees from Lantheus, AstraZeneca, Amgen, Daiichi, Convergent Therapeutics, Pfizer, ITM Isotope Technologies, Clarity Pharmaceuticals, Blue Earth Diagnostics, POINT Biopharma, Telix, Progenics, and Z-Alpha. BD reports grant support from the National Institutes of Health; participation on a data safety monitoring board or advisory board with Varian Medical Systems; and stock or stock options in Roche. AV reported receiving grants from MagArray Inc, Precyte Inc, Optellum Ltd, Lungevity Foundation, the Gordon and Betty Moore Foundation, and grants from the National Comprehensive Cancer Network; and personal fees from Johnson and Johnson, outside the submitted work. JEB reported receiving personal fees from Reimagine Care, Healthcare Foundry, and AstraZeneca; and grants from Loxo@Lilly, Gilead, and Emerson Collective outside the submitted work. The remaining authors have nothing to disclose. Acknowledgments Research reported in this publication was supported by the National Cancer Institute at the National Institutes of Health (Award Numbers: P50CA271338 [Bekelman/Rendle/Vachani]; P50CA271353 [Spring/Garcia/Hitsman/Phillips]; P50CA271357 [Panageas/Morris/Stetson]; P50CA271358 [Sherman/Makarov/Zullig]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'A Framework for Integrating Telehealth Equitably across the cancer care continuum'. Together they form a unique fingerprint.

Cite this